Position in TMO
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$3,878,019
+$742,550 QoQ
Shares Held
7,735
+21.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.71%
of 13F equity value
Holder Rank
#924
of 2,605 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority
Sole 79%
Shared 0%
None 21%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026First National Advisers, LLC holds $6,978,875 across 4 Diagnostics & Research names. TMO ranks #1 (55.6% of the industry book) .
All Filings in TMO
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,878,019 | 7,735 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $3,135,469 | 6,379 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $3,851,024 | 6,646 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $1,458,455 | 3,007 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $1,311,663 | 3,235 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $3,930,044 | 7,898 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $4,137,389 | 7,953 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $5,437,848 | 8,791 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $4,633,587 | 8,379 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $4,107,992 | 7,068 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $3,297,267 | 6,212 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $2,165,900 | 4,279 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,307,505 | 2,506 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $1,372,336 | 2,381 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $1,214,822 | 2,206 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $998,657 | 1,969 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $768,741 | 1,415 | Shares | Sole | 2022-08-12 | |
| No filing history on record for this holder in this stock. | ||||||